Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.
Madeline DevauxMathieu BoulinMorgane MounierDenis CaillotNuri AhwijAdélie HerbinJean Noël BastieCamille FavennecPhilippine RobertPauline PistreStephanie BostPauline AmiotLaurence JacquessonRené-Olivier CasasnovasCédric RossiPauline GueneauPublished in: Cancers (2022)
A nurse-pharmacist-haematologist collaboration seems to be promising to reduce grade 3-4 AEs in HL and NHL patients receiving highly haematotoxic chemotherapy regimens. Cost savings from hospitalisation being avoided were also shown.